Thus, based on pathological and molecular features, high FAT1 expression in breast cancer is most closely associated with ER/PR negative and TNBC/basal-like cases while lowest FAT1 expression occurs the ER+ and luminal B classifications. This evidence concerns the gene FAT1 and breast cancer.